Double Bond Pharmaceutical (DBP) has signed an agreement with Zoono for the distribution of selected products in the Scandinavian market. The sale of these products will be handled by it’s subsidiary Drugsson AB.Zoono provides cost effective, polymer based, broad-spectrum antimicrobial protection. The products are effective against bacteria, viruses, fungi (mould), yeasts, pathogens incl. MRSA, E.Coli, H1N1, Listeria, TB, black mould, Norovirus etc.Drugsson will market the products to both consumers (self-care) and healthcare, which shows that the products have a broad market."We are pleased to sign an agreement for the distribution of their products," says Igor Lokot, CEO of DBP. - Even more products to our portfolio have now been added and we will continue to acquire more”
News: ZNO Double Bond Pharma Signed A Distribution Agreement With Zoono, page-2
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZNO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.174M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80500 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 1937 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| ZNO (ASX) Chart |
Day chart unavailable